Solésence, Inc. reported a decline in financial performance for the first quarter of 2026, with total revenue decreasing to $12.96 million from $14.63 million in the same period of 2025. The company's product revenue, which constitutes the majority of its income, fell to $12.92 million, down from $14.58 million year-over-year. The decrease in revenue was attributed to lower sales in the consumer products and advanced materials categories, despite an increase in personal care ingredients sales. The company also recorded a net loss of $766,000, compared to a net income of $80,000 in the prior year, resulting in a loss per share of $0.01.
In terms of operational metrics, Solésence's total current assets decreased to $26.41 million as of March 31, 2026, from $28.78 million at the end of 2025. The company's cash reserves also saw a significant decline, dropping to $573,000 from $1.29 million. Current liabilities decreased to $12.69 million from $13.93 million, primarily due to a reduction in the line of credit related to accounts receivable. The company’s employee headcount increased, contributing to higher selling, general, and administrative expenses, which rose to $2.80 million from $2.11 million.
Strategically, Solésence continues to focus on its core markets in skin health and beauty, leveraging its proprietary technologies, including the Active Stress Defense™ suite. The company has been working on expanding its product offerings and enhancing its manufacturing capabilities to meet growing demand. Despite the challenges faced in the first quarter, Solésence remains committed to innovation and has plans to introduce new products in the coming months. The company is also exploring opportunities for geographic expansion beyond its primary North American market.
Looking ahead, Solésence anticipates that its revenue mix and volume will improve as it scales production and enhances operational efficiencies. The management has indicated that the company is focused on reducing variable manufacturing costs and improving gross margins. However, they also acknowledged potential challenges, including inflationary pressures on raw materials and labor costs, which could impact profitability. The company plans to continue monitoring market conditions and adjust its strategies accordingly to navigate these challenges effectively.
About SOLESENCE, INC.
Solesence, Inc. (formerly Nanophase Technologies) specializes in scientifically-driven skin health and beauty solutions, including proprietary active pharmaceutical ingredients (APIs) and fully formulated consumer products. The company develops mineral-based UV protection, environmental defense, and aesthetic skincare products for prestige and mass markets. Its core value lies in innovative nanotechnology, formulation expertise, and a vertically integrated business model serving global brand partners.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.